JZ3-18800-47062
3 vaccinations
2 coded responses
17 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 231 / VA
- Registered
- 2021-03-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-18
Registered in v-safe
-
2021-03-20
Dose 1 — Pfizer-BioNTech
- 2021-03-26
- 2021-03-27
- 2021-04-03
-
2021-04-10
Dose 2 — Pfizer-BioNTech
-
2021-04-17
Health check-in — day 7, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-24
- 2021-05-03
- 2021-05-08
- 2021-05-16
- 2021-05-22
-
2021-07-10
Survey response — 3 months, dose 2MedDRA: Medical counselling, Nasopharyngitis, Oropharyngeal pain — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Sore throat, cold-like symptoms. · Healthcare visit (other): Call to doctor who recommended a COVID testMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-10
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-13
-
2021-10-09
Survey response — 6 months, dose 2MedDRA: Abortion spontaneous, Uterine dilation and curettage — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · HospitalizationFree text: Symptoms: Had a miscarriage. · Healthcare visit (other): D&CMedDRA releases: 2024-11 · check-in free text available
-
2021-10-09
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
- 2021-10-12
-
2021-11-06
Dose 3 — Pfizer-BioNTech
- 2021-11-30
- 2021-12-04
- 2021-12-18
- 2022-02-05
- 2022-05-07
- 2022-11-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-20 | Pfizer-BioNTech | |
| 2 | 2021-04-10 | Pfizer-BioNTech | |
| 3 | 2021-11-06 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-10 | Unsuccessful | |
| 2021-10-09 | Unsuccessful |
Free text
Release 9 — 3 months, dose 2
Symptoms: Sore throat, cold-like symptoms.
Healthcare visit (other): Call to doctor who recommended a COVID test
Release 10 — 6 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | ✓ | ✓ | ✓ |
| HCVO | Uterine dilation and curettage | · | · | ✓ |
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release